At a glance
(thousands of €, if not stated otherwise) |
Second quarter of 2019 |
Second quarter of 2018 |
Six months ended 30 June 2019 |
Six months ended 30 June 2018 |
Full year 2018 |
||
Income statement |
|
|
|
|
|
||
|
|||||||
Revenues |
58,738 |
49,676 |
91,785 |
87,583 |
288,836 |
||
Other income |
8,852 |
7,358 |
16,724 |
14,289 |
29,009 |
||
R&D expenditure |
(94,372) |
(81,680) |
(177,567) |
(151,444) |
(322,875) |
||
S, G&A expenses |
(17,585) |
(9,104) |
(28,552) |
(16,214) |
(39,776) |
||
Operating expenses |
(111,958) |
(90,784) |
(206,119) |
(167,658) |
(362,652) |
||
Operating loss |
(44,367) |
(33,750) |
(97,610) |
(65,786) |
(44,807) |
||
Net financial results |
(2,820) |
12,052 |
1,834 |
6,867 |
15,598 |
||
Taxes |
(61) |
(75) |
(129) |
(137) |
(50) |
||
Net loss |
(47,249) |
(21,773) |
(95,905) |
(59,056) |
(29,259) |
||
Balance sheet |
|
|
|
|
|
||
Cash and cash equivalents |
1,147,923 |
1,066,766 |
1,147,923 |
1,066,766 |
1,290,796 |
||
R&D incentives receivables |
94,288 |
86,221 |
94,288 |
86,221 |
84,646 |
||
Assets(1) |
1,357,848 |
1,204,348 |
1,357,848 |
1,204,348 |
1,439,496 |
||
Shareholders' equity(1) |
1,143,367 |
885,659 |
1,143,367 |
885,659 |
1,214,249 |
||
Deferred income |
96,325 |
243,149 |
96,325 |
243,149 |
149,801 |
||
Other liabilities(1) |
118,157 |
75,539 |
118,157 |
75,539 |
75,446 |
||
Cash flow |
|
|
|
|
|
||
Operational cash burn |
(76,200) |
(53,656) |
(152,545) |
(95,009) |
(158,384) |
||
Cash flow used in operating activities |
(70,041) |
(51,476) |
(141,740) |
(91,278) |
(142,466) |
||
Cash flow used in investing activities |
(5,263) |
(2,193) |
(8,661) |
(3,724) |
(15,914) |
||
Cash flow generated in financing activities |
3,428 |
1,349 |
5,661 |
5,254 |
287,876 |
||
Increase / decrease (–) in cash and cash equivalents |
(71,876) |
(52,320) |
(144,740) |
(89,748) |
129,497 |
||
Effect of currency exchange rate fluctuation on cash and cash equivalents |
(3,102) |
10,899 |
1,866 |
5,304 |
10,089 |
||
Cash and cash equivalents at the end of the period |
1,147,923 |
1,066,766 |
1,147,923 |
1,066,766 |
1,290,796 |
||
Financial ratios |
|
|
|
|
|
||
Number of shares issued at the end of the period |
54,823,101 |
51,337,763 |
54,823,101 |
51,337,763 |
54,465,421 |
||
Basic and diluted loss per share (in €) |
(0.86) |
(0.42) |
(1.76) |
(1.16) |
(0.56) |
||
Share price at the end of the period (in €) |
113.45 |
78.94 |
113.45 |
78.94 |
80.56 |
||
Total group employees at the end of the period (number) |
837 |
675 |
837 |
675 |
725 |